Continuous Local Infusion of Anesthetic at the Incisional Site for Scoliosis Surgery

NCT00508066 · Status: COMPLETED · Phase: PHASE4 · Type: INTERVENTIONAL · Enrollment: 60

Last updated 2013-01-25

No results posted yet for this study

Summary

The purpose of this study is to evaluate the effects of continuous local anesthetic delivery on the immediate post-op recovery of patients undergoing spinal fusion surgery for congenital or idiopathic scoliosis.

Conditions

  • Scoliosis

Interventions

DRUG

Bupivacaine

Bupivacaine 0.25 - 0.5% @ 4ml/hr for 72 hours

DRUG

Normal Saline

Normal Saline, 4ml/hour for 72 hours.

Sponsors & Collaborators

  • Shriners Hospitals for Children

    lead OTHER

Principal Investigators

  • Norman Otsuka, MD · Shriners Hospitals for Children - Los Angeles

  • Anthony Scaduto, MD · Shriners Hospitals for Children - Los Angeles

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
TRIPLE
Model
PARALLEL

Eligibility

Min Age
8 Years
Max Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2007-05-31
Primary Completion
2011-01-31
Completion
2011-01-31

Countries

  • United States

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT00508066 on ClinicalTrials.gov